Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pinnita Prabhasawat, Mahidol University
ClinicalTrials.gov Identifier:
NCT01237600
First received: November 8, 2010
Last updated: December 5, 2011
Last verified: December 2011

November 8, 2010
December 5, 2011
January 2008
April 2011   (final data collection date for primary outcome measure)
Ocular surface status (signs of limbal deficiency and immunopathological markers) [ Time Frame: Three years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01237600 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction
Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction

The purpose of this study is to elucidate the appropriate condition of developing cultivated corneal epithelial graft and evaluate the surgical outcome of transplantation of the cultivated corneal epithelial stem cell in the patients.

Ocular surface damage caused by severe ocular surface diseases, particularly thermal and chemical burn or Stevens-Johnson syndrome result in corneal epithelial defect, corneal vascularization, corneal conjunctivalization and loss of transparency. Corneal limbal stem cell transplantation has been demonstrated to improve the outcome of ocular surface reconstruction. However, the conventional management of allograft limbal transplantation generally has unsatisfactory outcome because of high risk of rejection and requires long-life immunosuppressive medications.

Interventional
Phase 2
Phase 3
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Severe Ocular Surface Damage
  • Limbal Deficiency
Procedure: Cultivated limbal transplantation
Cultivated corneal epithelial stem cell transplantation. Autograft, Living related allograft, and Cadaveric allograft
Experimental: Cultivated limbal transplantation
Intervention: Procedure: Cultivated limbal transplantation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
November 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Unilateral/Bilateral limbal stem cell deficiency proved by specific clinical features and impression cytology result

Exclusion Criteria:

  • Age under 18
  • Active ocular infection, Severe dry eye, Uncontrolled glaucoma
  • Immunocompromised host
  • Pregnancy
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT01237600
447/2550(EC2)
No
Pinnita Prabhasawat, Mahidol University
Mahidol University
Not Provided
Principal Investigator: Pinnita Prabhasawat, MD Mahidol University
Mahidol University
December 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP